Accelerated Phase of Disease Completed Phase 1 Trials for Belinostat (DB05015)

IndicationStatusPhase
DBCOND0028537 (Accelerated Phase of Disease)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00351975Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other DiseasesTreatment